OTCMKTS:XCRP

Xcorporeal Stock Forecast, Price & News

$0.0030
0.00 (0.00 %)
(As of 04/9/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.00
Now: $0.00
$0.00
50-Day Range
$0.00
MA: $0.01
$0.01
52-Week Range
$0.00
Now: $0.00
$0.07
VolumeN/A
Average Volume6,200 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Beta3.62
Xcorporeal, Inc. is in the process of liquidation and dissolution, pursuant to the plan adopted by board of directors of the company on February 4, 2010. The company has formed the liquidating trust, Xcorporeal, Inc. Liquidating Trust, and transferred all of its assets to the trust for the purpose of completing the liquidation and dissolution of the company. Previously, it operated as a medical device company, which was engaged in the development of an extra-corporeal platform technology to be used in devices to replace the function of various human organs. Xcorporeal, Inc. was founded in 2001 and is based in Lake Forest, California.

Industry, Sector and Symbol

Industry Electromedical equipment
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:XCRP
CUSIPN/A
CIKN/A
Phone949-600-4621
Employees24
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Next Earnings DateN/A
OptionableNot Optionable

Headlines

No headlines for this company have been tracked by MarketBeat.com

MarketRank

Overall MarketRank

0.00 out of 5 stars

Medical Sector

1852nd out of 2,016 stocks

Electromedical Equipment Industry

57th out of 61 stocks

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
$0.0030
0.00 (0.00 %)
(As of 04/9/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive XCRP News and Ratings via Email

Sign-up to receive the latest news and ratings for XCRP and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Xcorporeal (OTCMKTS:XCRP) Frequently Asked Questions

What stocks does MarketBeat like better than Xcorporeal?

Wall Street analysts have given Xcorporeal a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Xcorporeal wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are Xcorporeal's key executives?

Xcorporeal's management team includes the following people:
  • Dr. Victor Gura M.D., Chief Scientific Officer, Chief Medical Officer and Member of Board of Advisors (Age 78, Pay $455.6k)
  • Mr. Terren S. Peizer, Exec. Director (Age 61, Pay $281.25k)
  • Mr. Len Braganza, VP of Sales & Marketing

Who are some of Xcorporeal's key competitors?

What is Xcorporeal's stock symbol?

Xcorporeal trades on the OTCMKTS under the ticker symbol "XCRP."

How do I buy shares of Xcorporeal?

Shares of XCRP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Xcorporeal's stock price today?

One share of XCRP stock can currently be purchased for approximately $0.00.

How many employees does Xcorporeal have?

Xcorporeal employs 24 workers across the globe.

What is Xcorporeal's official website?

The official website for Xcorporeal is www.xcorporeal.com.

Where are Xcorporeal's headquarters?

Xcorporeal is headquartered at 80 EMPIRE DRIVE, LAKE FOREST CA, 90025.

How can I contact Xcorporeal?

Xcorporeal's mailing address is 80 EMPIRE DRIVE, LAKE FOREST CA, 90025. The company can be reached via phone at 949-600-4621 or via email at [email protected]


This page was last updated on 4/13/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.